SureSeq™ NGS panels have been designed in collaboration with recognised cancer experts to detect key aberrations implicated in a wide range of haematological and solid tumour cancers. More so, you can always modify each panel to what’s relevant to your research with SureSeq myPanel, our regularly updated, expert-curated library of pre-optimised cancer content. Simply mix and match the gene, exonic or intronic content you need to create an NGS cancer panel that meets your exact requirements.
Our unique panel design coupled with hybridisation-based enrichment offers unparalleled coverage completeness and uniformity, allowing accurate detection of low-frequency SNVs and indels, as well as structural aberrations such as ITDs, PTDs, CNVs, LOH and translocations. Combined with our various SureSeq LPK products, SureSeq alleviates the burden of running multiple assays and streamlines your research, delivering comprehensive results using a single NGS workflow.
All SureSeq panels come with Interpret, our powerful and easy-to-use NGS analysis solution providing effortless translation of all your NGS data into meaningful results.